Welcome to our dedicated page for AvePoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AvePoint, Inc. filings document the company’s financial results, governance matters, capital structure and public-company securities activity. Form 8-K reports furnish quarterly and annual operating results, including SaaS revenue, total revenue, annual recurring revenue and related financial-condition disclosures tied to the company’s cloud data protection business.
Proxy materials and annual meeting reports cover director elections, executive compensation votes, auditor ratification and board governance. Other filings address common stock offering activity under shelf registration materials, the company’s secondary listing context for common stock, and the removal of AvePoint warrants from Nasdaq listing and registration.
AvePoint, Inc. (AVPT) insider filing shows Executive Chairman and Director reported open‑market sales of common stock on two dates. On 11/03/2025, 41,679 shares were sold at $13.96 per share. On 11/04/2025, 18,321 shares were sold at $13.80 per share.
The transactions were made under a Rule 10b5-1 trading plan adopted on June 22, 2025. Following these sales, the reporting person beneficially owned 15,040,668 shares indirectly, held by various trusts and LLCs for which he is affiliated or acts as trustee.
AvePoint (AVPT) reported an insider transaction by its Director and Chief Legal Officer. On October 24, 2025, the reporting person sold 1,848 shares of common stock at $15.03 per share under a Rule 10b5-1 plan adopted on December 18, 2024. Following the sale, the reporting person beneficially owned 631,893 shares, held directly. Beneficial ownership includes non‑RSU shares and RSUs subject to previously disclosed vesting schedules.
AvePoint (AVPT) disclosed an insider transaction by its Chief Executive Officer and director on 10/17/2025. The reporting person exercised stock options and acquired common shares in three transactions: 299,435, 158,634, and 37,974 shares, at exercise prices of $1.34, $1.59, and $3.91, respectively. After these exercises, the reporting person beneficially owned 2,153,502 shares, held directly.
The holdings reflect common stock and restricted stock units granted under AvePoint’s equity incentive plans, as noted in the footnotes.
AvePoint (AVPT) filed an amended Form 4 reporting that its Chief Executive Officer and Director exercised multiple stock option tranches on 10/13/2025 under the 2016 Equity Incentive Plan. The amendment adds these specific tranches to the prior filing.
The transactions (code M) cover options for 569,707 shares at an exercise price of $1.34, 362,850 shares at $1.59, and 1,716,047 shares at $3.91, each into common stock. Following these entries, the reported remaining derivative securities beneficially owned declined sequentially to 3,000,104, with ownership shown as Direct. Table I reflects no separate non-derivative share transactions in this excerpt.
AvePoint, Inc. (AVPT) CEO and Director reported an insider transaction. On 10/15/2025, the reporting person transferred 1,542,779 shares of common stock from direct ownership to River Valley Ltd. in connection with a loan repayment totaling $22,542,001, reported as a change in the form of ownership (Code J). The transaction carried a reported price of $14.61 per share.
Following the transaction, direct beneficial ownership was 1,657,459 shares. Indirect beneficial ownership was 15,384,632 shares, held by trusts and LLCs as noted. Footnotes state indirect holdings include shares at entities affiliated with or overseen by the reporting person.
AvePoint (AVPT) reported insider transactions by its Chief Executive Officer and Director on 10/13/2025. The reporting person exercised stock options (transaction code M) and acquired common stock (coded A) at an exercise price of $14.61 per share in three tranches of 569,707, 362,850, and 1,716,047 shares. Following these transactions, the reporting person directly beneficially owned 3,200,238 shares. The filing notes these holdings include vested and unvested RSUs granted under the company’s equity plans.
AvePoint, Inc. (AVPT) director and Executive Chairman Gong Xunkai reported two scheduled stock sales under a Rule 10b5-1 trading plan adopted on 06/22/2025. On 10/06/2025 he sold 55,833 shares at $15.31, and on 10/07/2025 he sold 4,167 shares at $15.08. After these transactions he is reported to beneficially own 15,100,668 shares held indirectly through several trusts and LLCs for which he serves as trustee or is an affiliate.
The filing notes the sales were effected pursuant to the pre-established trading plan and disclaims direct beneficial ownership of trust and LLC holdings except to the extent of pecuniary interest. The form was signed by an attorney-in-fact on 10/08/2025.
AvePoint, Inc. director and Executive Chairman Xunkai Gong reported a sale of 31,950 shares of common stock on 09/29/2025 at $15.34 per share under a Rule 10b5-1 trading plan adopted on 06/22/2025. The filing shows Mr. Gong beneficially owns 15,188,718 shares following the sale, held indirectly through several trusts and LLCs (Giocoso Holdings LLC, Cadenza Holdings LLC, Vivace Holdings LLC, The Purple Harbor Trust, The Purple Cove Trust, and G Sonata Trust). The report states he disclaims beneficial ownership of trust/LLC shares except to the extent of his pecuniary interest.
The transaction was reported on Form 4 and was executed pursuant to a pre-established trading plan, indicating the sale was planned rather than opportunistic based on undisclosed material information.
A holder of AvePoint, Inc. (AVPT) filed a Form 144 announcing a proposed sale of 240,000 Common Class A shares through The Charles Schwab Corporation. The filing lists an aggregate market value of $3,705,600 and shows approximately 211,926,808 shares outstanding, with an approximate sale date of 09/29/2025 on NASDAQ. The shares were acquired as founders shares from the issuer on 01/02/2006, and the filer reports no securities sold in the past three months.
AvePoint, Inc. insider sale of 35,000 common shares executed under a Rule 10b5-1 plan. The reporting person, Brian Michael Brown, who serves as Chief Legal Officer and a director, reported three sales totaling 35,000 shares on 09/23/2025 at prices between $15.49 and $15.59 per share. Following these transactions the filing shows beneficial ownership reported in the ranges of 650,474 down to 633,741 shares across the reported lines, which the filer states includes both non-RSU common stock and aggregate vested and unvested RSUs subject to previously reported vesting schedules. The filing notes the sales were made pursuant to a 10b5-1 trading plan adopted December 18, 2024.